Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
PARATHYROID HORMONE FORMULATIONS AND USES THEREOF
No-Receipt date
2011-01997 - 16/06/2011
No-Filing date
20110401427 - 16/06/2011
No-Granting date
3075265 - 17/06/2011
No-EPO application date
08842081.5 - 27/10/2008
No-EPO granting date
2219665 - 16/03/2011
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2011 - 14/07/2011
Expiration date
28/10/2028
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
EP0702101726/10/2007/EP
US996061 P26/10/2007/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 38/29
A61K 47/18
A61K 47/26
A61K 47/32
A61K 9/19
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
557393
TAKEDA PHARMA A/S
LANGEBJERG 1
4000 ROSKILDE
DENMARK
Inventors
Code
Firstname
Surname
860253
LOER LINDEROTH, DORTE
860254
LINDEGAARD HANSEN, LARS
Representatives
Code
Firstname
Surname
Address
Town
Zip
25
MARIA
ATHANASIADOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4007
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
15/07/2014
Αλλαγή Επωνυμίας Δικαιούχου (7e801)
ΑΡ.ΠΡΩΤ. 3118//27-5-2014,ΚΩΔ.ΠΛΗΡ. 1349
364389 Nycomed Danmark ApS Langebjerg 1 ΔΑΝΙΑ 4000 Roskilde
557393 TAKEDA PHARMA A/S Langebjerg 1 ΔΑΝΙΑ 4000 Roskilde
Title Instruments
Date
Operation
Descreption
5/4/2017 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 04/2017 Αρ. Πρωτ. ΓΔ 770/4.5.2017
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).